Show simple item record

dc.contributor.authorTsoi, Daniel T.
dc.date.accessioned2017-08-24T14:52:46Z
dc.date.available2017-08-24T14:52:46Z
dc.date.issued2011
dc.identifier.citationKnibbs, N. & Tsoi, D. T. (2011). Varenicline induces manic relapse in bipolar disorder. General Hospital Psychiatry, 33 (6), pp.641.e1-641.e2.
dc.identifier.other10.1016/j.genhosppsych.2011.05.008
dc.identifier.urihttp://hdl.handle.net/20.500.12904/12200
dc.description.abstractVarenicline (Chantix) is commonly used to assist individuals with smoking cessation. This medication is known to affect mood and behavior. We report a patient with bipolar disorder who developed manic relapse after starting treatment with varenicline for tobacco dependence. Further research is necessary to establish the safety of using varenicline in individuals who have significant mental illness and want to stop smoking.
dc.description.urihttp://www.ghpjournal.com/article/S0163-8343(11)00182-4/pdf
dc.subjectBipolar disorder
dc.subjectSmoking cessation
dc.titleVarenicline induces manic relapse in bipolar disorder
dc.typeArticle


This item appears in the following Collection(s)

Show simple item record